|
Dr. Kay is the Director of Clinical Trials in the MGH Rheumatology Unit and an Associate Clinical Professor of Medicine at Harvard. Dr. Kay has been a principal investigator on over 30 clinical trials of novel therapies for rheumatoid arthritis, gout and osteoarthritis. He is the author of more than 50 publications and book chapters and is internationally recognized as a leader improving the clinical practice of rheumatology.
Dr. Kay received his undergraduate degree from Harvard University and his medical degree from the University of California School of Medicine in San Francisco. He completed training in Internal Medicine at the Hospital of the University of Pennsylvania and fellowships in Rheumatology and Immunology at the Brigham and Women's Hospital and Harvard Medical School in Boston.
| 